Overview

Extension of Study ZPV-200

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety, pharmacokinetics and efficacy of four doses of vaginally administered Proellex in premenopausal women with uterine fibroids confirmed by ultrasound.

Phase:

Phase 2

Details

Lead Sponsor:

Repros Therapeutics Inc.